Louis Moy

Humphrey O. Atiemo, MD
Glickman Urological Institute, Cleveland Clinic

Louis Moy, MD
University of Pennsylvania, Philadelphia

Sandip Vasavada, MD
Glickman Urological Institute, Cleveland Clinic,

Raymond Rackley, MD
Glickman Urological Institute, Cleveland Clinic

Address: Raymond Rackley, MD, Glickman Urological Institute, A100, Cleveland Clinic, 9500 Euclid Avenue, Cleveland, OH 44195; e-mail: [email protected]

Dr. Atiemo has indicated that he is on the speaker's bureau of the Pfizer corporation.

Dr. Vasavada has indicated that he serves as a consultant or on the speaker's bureaus of the Novartis and Pfizer corporations and owns stock in the Neurostim Design and Innovation Medical corporation.

Dr. Rackley has indicated that he has received grant or research support from the Allergan and Novartis corporations and the Interstitial Cystitis Association; serves as a consultant or on the speaker's bureau of the Allergan, American Medical Systems, Astellas, Boston Scientific, Novartis, and Pfizer corporations; and owns stock in the Neurostim Design and Innovation Medical corporation.

Humphrey O. Atiemo, MD
Glickman Urological Institute, Cleveland Clinic

Louis Moy, MD
University of Pennsylvania, Philadelphia

Sandip Vasavada, MD
Glickman Urological Institute, Cleveland Clinic,

Raymond Rackley, MD
Glickman Urological Institute, Cleveland Clinic

Address: Raymond Rackley, MD, Glickman Urological Institute, A100, Cleveland Clinic, 9500 Euclid Avenue, Cleveland, OH 44195; e-mail: [email protected]

Dr. Atiemo has indicated that he is on the speaker's bureau of the Pfizer corporation.

Dr. Vasavada has indicated that he serves as a consultant or on the speaker's bureaus of the Novartis and Pfizer corporations and owns stock in the Neurostim Design and Innovation Medical corporation.

Dr. Rackley has indicated that he has received grant or research support from the Allergan and Novartis corporations and the Interstitial Cystitis Association; serves as a consultant or on the speaker's bureau of the Allergan, American Medical Systems, Astellas, Boston Scientific, Novartis, and Pfizer corporations; and owns stock in the Neurostim Design and Innovation Medical corporation.

Humphrey O. Atiemo, MD
Glickman Urological Institute, Cleveland Clinic

Louis Moy, MD
University of Pennsylvania, Philadelphia

Sandip Vasavada, MD
Glickman Urological Institute, Cleveland Clinic,

Raymond Rackley, MD
Glickman Urological Institute, Cleveland Clinic

Address: Raymond Rackley, MD, Glickman Urological Institute, A100, Cleveland Clinic, 9500 Euclid Avenue, Cleveland, OH 44195; e-mail: [email protected]

Dr. Atiemo has indicated that he is on the speaker's bureau of the Pfizer corporation.

Dr. Vasavada has indicated that he serves as a consultant or on the speaker's bureaus of the Novartis and Pfizer corporations and owns stock in the Neurostim Design and Innovation Medical corporation.

Dr. Rackley has indicated that he has received grant or research support from the Allergan and Novartis corporations and the Interstitial Cystitis Association; serves as a consultant or on the speaker's bureau of the Allergan, American Medical Systems, Astellas, Boston Scientific, Novartis, and Pfizer corporations; and owns stock in the Neurostim Design and Innovation Medical corporation.